Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer
| Autor: | Neda Ketabchi, Iman Seyhoun, Maria Kavianpour, Mahshid Saleh, Somayeh Ebrahimi-Barough, Negar Noorbakhsh, Javad Verdi |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Carcinogenesis
business.industry Medicine (miscellaneous) Cancer General Medicine Tumor-Derived Exosomes medicine.disease_cause medicine.disease Microvesicles Metastasis MicroRNAs Immune system Neoplasms microRNA Biomarkers Tumor Tumor Microenvironment medicine Cancer research Humans Cancer vaccine business |
| Zdroj: | Current Stem Cell Research & Therapy. 17:91-102 |
| ISSN: | 1574-888X |
| DOI: | 10.2174/1574888x16666210622123942 |
| Popis: | A tumor is an abnormal growth of cells within a tissue that can lead to death due to late diagnosis, poor prognosis, drug resistance, and finally enhanced metastasis formation. Exosomes are nanovesicles that have been derived from all the different cell types. These vesicles can transfer various molecules, including the distinct form of nucleic acids (mRNA, miRNA, and circRNA) and proteins. Tumor-derived exosomes (TEXs) have exceptionally important roles through multiple molecular and cellular pathways like progression, tumorigenesis, drug resistance, and as well as metastasis. TEXs are detectable in all body fluids such as serum and urine, a convenient and non-invasive way to access these nano-sized vesicles. TEXs lead to the symptom expression of genetic aberrations in the tumor cell population, making them an accurate and sensitive biomarker for the diagnosis and prognosis of tumors. On the other hand, TEXs contain major histocompatibility complexes (MHCs) and play important dual roles in regulating tumor immune responses: they can mediate both immune activation and suppression through tumor-associated immunity. Despite numerous scientific studies, there are still many technical barriers to distinguish TEXs from non-tumor-derived exosomes. Even so, removing exosomes leading to a wide difference in outcomes inside a patient's body. Hence, controversial pieces of evidence have demonstrated the vital role of TEXs as hopeful biomarkers for the early detection of cancers, evaluation of therapeutic effects, and monitoring of the patient. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|